Editing Evaluation and Management of Erectile Dysfunction (section)

== Questions ==

# What are the mandatory investigations in a patient with erectile dysfunction as per the AUA/CUA?
# What are the recommended investigations in a patient with erectile dysfunction as per the AUA/CUA?
# As per the 2021 CUA Guidelines on Erectile Dysfunction, what are the indications to measure serum testosterone?
# What are the 5 domains of the International Index of Erectile Function (IIEF)?
# List potential specialized testing options in the evaluation of erectile dysfunction
# List the FDA-approved PDE5 inhibitors for the treatment of ED
# What are the contraindications to PDE5 inhibitors?
# Which PDE5 inhibitor is not recommended in patients who take type 1A antiarrhythmics (e.g., quinidine or procainamide) or type 3 antiarrhythmics (e.g., sotalol or amiodarone) or in patients with congenital prolonged QT syndrome?
# What are potential adverse events related to the use of a PDE5i?
# Which PDE5 inhibitors have higher rates of visual disturbances? Myalgia?
# What is the onset of action, T1/2, and effect of food intake on the different PDE5 inhibitors?
# What are the non-surgical treatment options for erectile dysfunction?
# What are the contraindications to intraurethral alprostadil?
# What are the typical medications in intracavernosal injection?
# What are the contraindications to intracavernosal injections?
# What are potential complications of penile prosthesis surgery?